Canadian Reimbursement and Forecasting Timelines (CRaFT) Subscription

2026 Coming Soon

PRE-ORDER NOW

2026 CRaFT Subscription

MORSE Consulting will be launching our 2026 Canadian Reimbursement and Forecasting Timelines (CRaFT) Subscription in May. Download a Sample of the Report. A CRaFT Subscription provides clients with access to in-depth public market access volume and timeline analyses using MORSE’s robust public payer dataset, paired with insights tapped from MORSE’s unparalleled HTA and public payer expertise.   This year’s CRaFT Subscription includes access to the following:  

2026 edition of CRaFT Report, encompassing:

- CDA volume & timeline metrics

- CDA & INESSS alignment in recommendations

- pCPA volume & timeline metrics, and negotiation trends

- Provincial funding volume & timeline metrics

- Subset analyses including pCPA Temporary Access Process (pTAP), Early Negotiation Process (ENP), Targeted Negotiation Process (TNP), subsequent indication negotiation

- Data stratification by Oncology, Non-Oncology, and Others

Monthly Market Access Update, which will provide timely and up-to-date information on files moving through the market access process, including an in-depth analysis of CDA and pCPA metrics with relevant insights on emerging trends.

Mid-year Update of listing data from BC, AB, ON, and QC

Additionally, this year’s add-ons for purchase include:  

Drug for Rare Diseases (DRD) sub-report

Together, these reports and insights are a comprehensive source of reimbursement timeline information to assist companies with their upcoming Canadian launch.

For further information on content and pricing, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.

We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

Pre-Order: Canadian Reimbursement and Forecasting Timelines (CRaFT) 2026, May 2025 Update

Canadian Reimbursement and Forecasting Timelines (CRaFT) Subscription

PRE-ORDER NOW

2026 CRaFT Subscription

For further information on content and pricing, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.

You're viewing an older edition